Division of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30329, USA.
Foodborne Pathog Dis. 2011 Dec;8(12):1289-94. doi: 10.1089/fpd.2011.0944. Epub 2011 Sep 1.
Salmonella enterica is one of the most common bacterial causes of foodborne illness, and nontyphoidal Salmonella is estimated to cause ∼1.2 million illnesses in the United States each year. Plasmids are mobile genetic elements that play a critical role in the dissemination of antimicrobial resistance determinants. AmpC-type CMY β-lactamases (bla(CMY)) confer resistance to extended-spectrum cephalosporins and β-lactam/β-lactamase inhibitor combinations and are commonly plasmid-encoded. A variety of plasmids have been shown to encode CMY β-lactamases and certain plasmids may be associated with particular Salmonella serotypes or environmental sources. In this study, we characterized bla(CMY) β-lactamase-encoding plasmids among Salmonella isolates. Isolates of Salmonella from specimens collected from humans in 2007 were submitted to the Centers for Disease Control and Prevention National Antimicrobial Resistance Monitoring System laboratory for susceptibility testing. Three percent (65/2161) of Salmonella isolates displayed resistance to ceftriaxone (minimum inhibitory concentration [MIC] ≥4 mg/L) and amoxicillin/clavulanic acid (MIC ≥32 mg/L), a combination associated with the presence of a bla(CMY) mechanism of resistance. Sixty-four (98.5%) isolates were polymerase chain reaction-positive for bla(CMY) genes. Transformation and conjugation studies showed that 95% (61/64) of the bla(CMY) genes were plasmid-encoded. Most of the bla(CMY)-positive isolates were serotype Typhimurium, Newport, Heidelberg, and Agona. Forty-three plasmids were replicon type IncA/C, 15 IncI1, 2 contained multiple replicon loci, and 1 was untypeable. IncI1 plasmids conferred only the bla(CMY)-associated resistance phenotype, whereas IncA/C plasmids conferred additional multi-drug resistance (MDR) phenotypes to drugs such as chloramphenicol, sulfisoxazole, and tetracycline. Most of the IncI1 plasmids (12/15) were sequence type 12 by plasmid multi-locus sequence typing. CMY β-lactamase-encoding plasmids among human isolates of Salmonella in the United States tended to be large MDR IncA/C plasmids or single resistance determinant IncI1 plasmids. In general, IncI1 plasmids were identified among serotypes commonly associated with poultry, whereas IncA/C plasmids were more likely to be identified among cattle/beef-associated serotypes.
肠炎沙门氏菌是食源性疾病最常见的细菌病原体之一,据估计,每年在美国有 120 万人因非伤寒型肠炎沙门氏菌而患病。质粒是移动遗传元件,在传播抗生素耐药决定因素方面起着关键作用。AmpC 型 CMY β-内酰胺酶(bla(CMY))对广谱头孢菌素和β-内酰胺/β-内酰胺酶抑制剂组合具有耐药性,通常由质粒编码。已经证明多种质粒可编码 CMY β-内酰胺酶,并且某些质粒可能与特定的沙门氏菌血清型或环境来源有关。在这项研究中,我们对沙门氏菌分离株中的 bla(CMY)β-内酰胺酶编码质粒进行了表征。从 2007 年从人类标本中采集的沙门氏菌分离株被提交给疾病预防控制中心国家抗生素耐药性监测系统实验室进行药敏试验。3%(65/2161)的沙门氏菌分离株对头孢曲松(最低抑菌浓度 [MIC]≥4mg/L)和阿莫西林/克拉维酸(MIC≥32mg/L)表现出耐药性,这两种药物的组合与 bla(CMY)耐药机制的存在有关。64(98.5%)个分离株的 bla(CMY)基因经聚合酶链反应呈阳性。转化和接合研究表明,95%(61/64)的 bla(CMY)基因由质粒编码。大多数 bla(CMY)阳性分离株为肠炎沙门氏菌、纽波特沙门氏菌、海德堡沙门氏菌和阿贡纳沙门氏菌。43 个质粒为 IncA/C 复制子型,15 个为 IncI1,2 个包含多个复制子位点,1 个无法定型。IncI1 质粒仅赋予 bla(CMY)相关的耐药表型,而 IncA/C 质粒赋予氯霉素、磺胺甲噁唑和四环素等药物的其他多药耐药(MDR)表型。大多数 IncI1 质粒(12/15)通过质粒多位点序列分型为 12 型序列类型。美国人类沙门氏菌分离株中的 bla(CMY)β-内酰胺酶编码质粒往往是大的 MDR IncA/C 质粒或单个耐药决定因素 IncI1 质粒。一般来说,IncI1 质粒在与家禽有关的血清型中被发现,而 IncA/C 质粒在与牛/牛肉有关的血清型中更可能被发现。